BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15196675)

  • 1. A novel melatonin derivative modulates sleep-wake cycle in rats.
    Akanmu MA; Songkram C; Kagechika H; Honda K
    Neurosci Lett; 2004 Jul; 364(3):199-202. PubMed ID: 15196675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrodotoxin inactivation of pontine regions: influence on sleep-wake states.
    Sanford LD; Yang L; Tang X; Ross RJ; Morrison AR
    Brain Res; 2005 May; 1044(1):42-50. PubMed ID: 15862788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fluoromethylhistidine, a histamine synthesis inhibitor, inhibits orexin-induced wakefulness in rats.
    Yasuko S; Atanda AM; Masato M; Kazuhiko Y; Kazuki H
    Behav Brain Res; 2010 Feb; 207(1):151-4. PubMed ID: 19818811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.
    Olive MF; Seidel WF; Edgar DM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
    Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
    Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective neuronal nitric oxide synthase inhibition on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):56-67. PubMed ID: 16023276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of a light-dark profile and the pineal gland on the hypnotic activity of melatonin in mice and rats.
    Wang F; Li JC; Wu CF; Yang JY; Zhang RM; Chai HF
    J Pharm Pharmacol; 2003 Sep; 55(9):1307-12. PubMed ID: 14604475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP; Davidson K; Kulla A; Sugden D
    J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity.
    Sanford LD; Yang L; Liu X; Tang X
    Brain Res; 2006 Apr; 1084(1):80-8. PubMed ID: 16546144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
    Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
    Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M; Niskanen L; Kangas AP; Koskinen T
    Nord J Psychiatry; 2005; 59(3):217-21. PubMed ID: 16195124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep.
    Sanford LD; Yang L; Tang X; Dong E; Ross RJ; Morrison AR
    Neuroscience; 2006 Sep; 141(4):2167-76. PubMed ID: 16843604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
    Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
    Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal REM sleep is regulated by corticotropin releasing factor.
    Feng P; Liu X; Vurbic D; Fan H; Wang S
    Behav Brain Res; 2007 Aug; 182(1):95-102. PubMed ID: 17588683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness.
    Thakkar MM; Engemann SC; Walsh KM; Sahota PK
    Neuroscience; 2008 Jun; 153(4):875-80. PubMed ID: 18440150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
    Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin as a hypnotic: con.
    van den Heuvel CJ; Ferguson SA; Macchi MM; Dawson D
    Sleep Med Rev; 2005 Feb; 9(1):71-80. PubMed ID: 15649741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans.
    Hughes RJ; Badia P
    Sleep; 1997 Feb; 20(2):124-31. PubMed ID: 9143072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.